Search results for "Venous thromboembolism"
Sepsis cultures, resuscitation score, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/04/recent-research.htm
15 Apr 2020
December issue online and in the mail
The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019
Venous thromboembolism in malignancy
Patients with a VTE have more than a fourfold increased risk for cancer compared with the general population. In patients with a known malignancy, the annual incidence of VTE is 1 in 200.
https://acphospitalist.acponline.org/archives/2017/03/expert-analysis-vte-malignancy.htm
15 Mar 2017
Hospitals' volume of PE treatment associated with 30-day PE-related mortality
Patients treated for pulmonary embolism (PE) at hospitals that saw at least 40 PEs per year had about half the rate of mortality from PE as patients treated at hospitals that saw fewer than 15 PEs per year.
https://acphospitalist.acponline.org/weekly/archives/2019/08/07/2.htm
7 Aug 2019
An agenda for hospitalists' research
The pandemic added opportunities and barriers to an already challenged field.
https://acphospitalist.acponline.org/archives/2021/05/an-agenda-for-hospitalists-research.htm
15 May 2021
Latest research looks at clots, drug therapies, and pneumonia guidance
Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/05/13/2.htm
13 May 2020
Venous thromboembolism in the elderly
Venous thromboembolism (VTE) is manifested clinically by deep venous thrombosis (DVT) and pulmonary embolism (PE). DVT, usually of the lower extremity, nearly always precedes PE.
https://acphospitalist.acponline.org/archives/2007/04/elderly.htm
15 Apr 2007
Rivaroxaban at discharge did not significantly reduce deaths due to VTE, study finds
Patients who were randomized to 45 days of rivaroxaban instead of placebo did have lower risk of nonfatal venous thromboembolism (VTE), the industry-funded trial found.
https://acphospitalist.acponline.org/weekly/archives/2018/08/29/1.htm
29 Aug 2018
The battle for high-value care
Experts give their advice on value projects and the evidence on stress tests and clot prophylaxis.
https://acphospitalist.acponline.org/archives/2019/12/the-battle-for-high-value-care.htm
15 Dec 2019
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020